Is Daratumumab Being Used in the Frontline Setting for Myeloma Patients? (https://www.myeloma.org/videos/daratumumab-being-used-frontline-setting-myeloma-patients)
|
In this week’s video, Dr. Brian G.M. Durie discusses daratumumab’s presence and results in the frontline setting. BOTTOM LINE: |
|||
Have a question? Submit it to [email protected] (mailto:[email protected]) |
|||
|
IMF Chairman Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to [email protected] (mailto:[email protected])! |
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.